H. Kadali

Assessment of Vedolizumab Disease‐Drug‐Drug Interaction Potential in Patients With Inflammatory Bowel Diseases

J. Aubrecht, J. Schneider, P. Gulati, 2020, Clinical pharmacology in drug development.

Vedolizumab Concentrations in Breast Milk: Results from a Prospective, Postmarketing, Milk-Only Lactation Study in Nursing Mothers with Inflammatory Bowel Disease

Dawn B. Beaulieu, R. Arsenescu, D. Beaulieu, 2021, Clinical Pharmacokinetics.

Pharmacokinetics, Safety and Efficacy of Intravenous Vedolizumab in Paediatric Patients with Ulcerative Colitis or Crohn’s Disease: Results from the Phase 2 HUBBLE Study

D. Turner, J. Hyams, S. Kabilan, 2022, Journal of Crohn's & colitis.

885: TRIPLE COMBINATION THERAPY WITH VEDOLIZUMAB, ADALIMUMAB, AND METHOTREXATE IN PATIENTS WITH HIGH-RISK CROHN'S DISEASE: INTERIM ANALYSIS FROM THE OPEN-LABEL, PHASE 4 EXPLORER TRIAL

B. Sands, C. Siegel, J. Valentine, 2022, Gastroenterology.

Oral Orexin Receptor 2 Agonist in Narcolepsy Type 1.

E. Mignot, G. Plazzi, T. Scammell, 2023, The New England journal of medicine.